Literature DB >> 21797965

Racial differences in venous thromboembolism.

N A Zakai1, L A McClure.   

Abstract

The incidence of venous thrombosis (VTE) varies by race, with African-Americans having over 5-fold greater incidence than Asian-ancestry populations, and an intermediate risk for European and Hispanic populations. Known racial differences in genetic polymorphisms associated with thrombosis do not account for this gradient of risk, nor do known racial variations in environmental risk factors. Data on the incidence of and risk factors for VTE outside of Europe and North America and in non-European ancestry populations are sparse. Common genetic polymorphisms in European-Ancestry populations, such as factor V Leiden and prothrombin G20210A, and environmental risk factors, such as obesity, may account for some of the increased risk in European populations, and high factor VIII, high von Willebrand factor and low protein C levels and increased prevalence of obesity may explain some of the increased risk in African-Americans. The low rates in Asian populations may be partially explained by low clinical suspicion in a perceived low-risk population and lack of access to healthcare in other populations. As risk factors for thrombosis, such as surgery and treatment for cancer, are applicable to more people, as obesity increases in prevalence in the developing world, and as surveillance systems for VTE improve, VTE may increase in previously low-risk populations. While differences in VTE by race due to genetic predisposition will probably always be present, understanding the reasons for racial differences in VTE will help providers develop strategies to minimize VTE in all populations.
© 2011 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2011        PMID: 21797965     DOI: 10.1111/j.1538-7836.2011.04443.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  67 in total

1.  Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.

Authors:  Zhen Wang; Hong-Hong Yan; Jin-Ji Yang; Bin-Chao Wang; Hua-Jun Chen; Qing Zhou; Chong-Rui Xu; Ben-Yuan Jiang; Yi-Long Wu
Journal:  Support Care Cancer       Date:  2014-08-27       Impact factor: 3.603

2.  Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.

Authors:  Neil A Zakai; Leslie A McClure; Suzanne E Judd; Monika M Safford; Aaron R Folsom; Pamela L Lutsey; Mary Cushman
Journal:  Circulation       Date:  2014-02-07       Impact factor: 29.690

3.  "East asian paradox": challenge for the current antiplatelet strategy of "one-guideline-fits-all races" in acute coronary syndrome.

Authors:  Young-Hoon Jeong
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

4.  COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.

Authors:  Antonio Coppola; Maria Lombardi; Maria I Tassoni; Gaetano Carolla; Maurizio Tala; Rossella Morandini; Oriana Paoletti; Sophie Testa
Journal:  Blood Transfus       Date:  2020-05       Impact factor: 3.443

Review 5.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

6.  High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.

Authors:  Amanda B Payne; Connie H Miller; W Craig Hooper; Cathy Lally; Harland D Austin
Journal:  Ethn Dis       Date:  2014       Impact factor: 1.847

Review 7.  Review of venous thromboembolism and race: the generalizability of treatment guidelines for high-risk populations.

Authors:  Lonnie T Sullivan; Larry R Jackson; Kevin L Thomas
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 8.  Dysfunction of protein C anticoagulant system, main genetic risk factor for venous thromboembolism in northeast Asians.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  J Thromb Thrombolysis       Date:  2014-01       Impact factor: 2.300

9.  Common genetic risk factors for venous thrombosis in the Chinese population.

Authors:  Liang Tang; Hua-Fang Wang; Xuan Lu; Xiao-Rong Jian; Bi Jin; Hong Zheng; Yi-Qing Li; Qing-Yun Wang; Tang-Chun Wu; Huan Guo; Hui Liu; Tao Guo; Jian-Ming Yu; Rui Yang; Yan Yang; Yu Hu
Journal:  Am J Hum Genet       Date:  2013-01-17       Impact factor: 11.025

Review 10.  Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis.

Authors:  Kang-Ling Wang; Pao-Hsien Chu; Cheng-Han Lee; Pei-Ying Pai; Pao-Yen Lin; Kou-Gi Shyu; Wei-Tien Chang; Kuan-Ming Chiu; Chien-Lung Huang; Chung-Yi Lee; Yen-Hung Lin; Chun-Chieh Wang; Hsueh-Wei Yen; Wei-Hsian Yin; Hung-I Yeh; Chern-En Chiang; Shing-Jong Lin; San-Jou Yeh
Journal:  Acta Cardiol Sin       Date:  2016-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.